GGrantIndex
← Leaderboards

Wally R Smith

Virginia Commonwealth University

$9,055,907
Attributed
$10,318,465
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,507,828 · 11
AHRQ$1,253,920 · 1

By mechanism

R01$3,413,619 · 2
R18$3,331,112 · 1
U54$2,206,834 · 3
U24$1,893,837 · 1
U10$903,830 · 1
M01$12,516 · 4

Top collaborators

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Top investigators on “Sickle Cell Anemia

Research focus

Sickle Cell AnemiaPainProgramsAdultUnited States National Institutes Of HealthVirginiaHydroxyureaSickle CellClinical ResearchProviderAcademic Medical CentersPhysiciansCaringTrainingFundingHuman SubjectResearch PersonnelBiologyHemoglobinSicklingEpidemiologyPharmaceutical PreparationsUniversitiesQuality Of Life

Grant awards (30)

Sickle Cell Disease Pain Analgesia And Integrative Network$929,890
U24 · FY2025 · AT
Sickle Cell Disease Pain Analgesia And Integrative Network$963,947
U24 · FY2024 · AT
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators$226,959
R18 · FY2017 · HL · contact PI
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators$594,619
R18 · FY2016 · HL · contact PI
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators$592,410
R18 · FY2015 · HL · contact PI
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators$595,558
R18 · FY2014 · HL · contact PI
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators$671,207
R18 · FY2013 · HL · contact PI
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators$650,359
R18 · FY2012 · HL · contact PI
Virginia Basic and Translational Research Program$468,513
U54 · FY2011 · HL · contact PI
Career Development for a Sickle Cell Scholar$148,264
U54 · FY2011 · HL · contact PI
Administrative Core$96,237
U54 · FY2011 · HL · contact PI
Comparative Effectiveness of Virginia Coordinated Care versus the Traditional Saf$1,253,920
R01 · FY2010 · HS · contact PI
MORPHINE PHARMACOKINETICS AND PHARMACODYNAMICS IN SICKLE CELL DISEASE$8,215
M01 · FY2010 · RR · contact PI
Virginia Basic and Translational Research Program$490,025
U54 · FY2009 · HL · contact PI
Career Development for a Sickle Cell Scholar$156,975
U54 · FY2009 · HL · contact PI
Administrative Core$101,892
U54 · FY2009 · HL · contact PI
Virginia Comprehensive Sickle Cell Center-Center: Basic & Translational Research$484,745
U54 · FY2008 · HL · contact PI
Virginia Commonwealth University Sickle Cell Disease Clinical Network$301,166
U10 · FY2008 · HL · contact PI
Career Development for a Sickle Cell Scholar$156,451
U54 · FY2008 · HL · contact PI
Administrative Core$103,732
U54 · FY2008 · HL · contact PI
Virginia Commonwealth University Sickle Cell Disease Clinical Network$298,203
U10 · FY2007 · HL · contact PI
Virginia Commonwealth University Sickle Cell Disease$304,461
U10 · FY2006 · HL · contact PI
MULTI-CENTER STUDY OF HYDROXYUREA IN SICKLE CELL ANEMIA (MSH) PATIENTS FOLLOW$633
M01 · FY2006 · RR · contact PI
Pain in Sickle Cell Epidemiology Study (PiSCES)$3,020
M01 · FY2004 · RR
PAIN IN SICKLE CELL EPIDEMIOLOGIC STUDY$815,967
R01 · FY2003 · HL
PAIN IN SICKLE CELL EPIDEMIOLOGIC STUDY$30,000
R01 · FY2003 · HL
PAIN IN SICKLE CELL EPIDEMIOLOGIC STUDY$683,639
R01 · FY2002 · HL
PAIN IN SICKLE CELL EPIDEMIOLOGIC STUDY$630,093
R01 · FY2001 · HL
MULTICENTER STUDY OF HYDROXYUREA 5 YEARS FOLLOW-UP STUDY$0
M01 · FY2001 · RR
MULTICENTER STUDY OF HYDROXYUREA 5 YEARS FOLLOW-UP STUDY$648
M01 · FY2000 · RR